The merger of 'sanofi-aventis' as an example for Reasons and Consequences of Mergers and Acquistions in the Pharmaceutical Industry

Business & Finance, Marketing & Sales
Cover of the book The merger of 'sanofi-aventis' as an example for Reasons and Consequences of Mergers and Acquistions in the Pharmaceutical Industry by Martin Wenderoth, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Martin Wenderoth ISBN: 9783640267033
Publisher: GRIN Verlag Publication: February 13, 2009
Imprint: GRIN Verlag Language: English
Author: Martin Wenderoth
ISBN: 9783640267033
Publisher: GRIN Verlag
Publication: February 13, 2009
Imprint: GRIN Verlag
Language: English

Essay from the year 2008 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: (4) good, Eötvös Loránd Tudományegytem (International PhD Program), course: Business Economics, 22 entries in the bibliography, language: English, abstract: Within the ongoing globalisation process, many national markets and industrial branches are in different phases of the transition from local to global economic structures (Bryan, L.; Fraser, J.; Oppenheim, J. Rall, W., 2000, pp. 71-95). As a result of this development organisations in the different industries are increasingly concentrating (Brühl, V., 2003, pp. 274-278). Among other industries, also the pharmaceutical industry is highly influenced by the above mentioned trend, reflected by the increasing number of mergers and acquisitions (M&A's) in the pharmaceutical industry, which is illustrated in the following figure. Figure 1: The present assignment is going to evaluate the reasons and consequences of M&A's within the pharmaceutical industry by using the sanofi-aventis merger as an example. First of all, the recent history of sanofi-aventis is briefly described. The third part will describe the reasons and consequences of mergers and acquisitions in the pharmaceutical industry by describing the challenges the pharmaceutical branch is confronted with and the respective motives of and results from M&A activities. Finally, the major findings are summarised and conclusions will be derived. 2. History of sanofi-aventis Following the company homepage of sanofi-aventis (20071), the year 1999 has been very im-portant because of two reasons. First of all, Sanofi took over the Synthelabo Holding GmbH and changed its company name to Sanofi-Synthelabo. Furthermore, Hoechst merged with Rhône-Poulenc, a French chemical and pharmaceutical organisation in order to form the new company Aventis, with its legal seat in Strassbourgh (...)

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Essay from the year 2008 in the subject Business economics - Marketing, Corporate Communication, CRM, Market Research, Social Media, grade: (4) good, Eötvös Loránd Tudományegytem (International PhD Program), course: Business Economics, 22 entries in the bibliography, language: English, abstract: Within the ongoing globalisation process, many national markets and industrial branches are in different phases of the transition from local to global economic structures (Bryan, L.; Fraser, J.; Oppenheim, J. Rall, W., 2000, pp. 71-95). As a result of this development organisations in the different industries are increasingly concentrating (Brühl, V., 2003, pp. 274-278). Among other industries, also the pharmaceutical industry is highly influenced by the above mentioned trend, reflected by the increasing number of mergers and acquisitions (M&A's) in the pharmaceutical industry, which is illustrated in the following figure. Figure 1: The present assignment is going to evaluate the reasons and consequences of M&A's within the pharmaceutical industry by using the sanofi-aventis merger as an example. First of all, the recent history of sanofi-aventis is briefly described. The third part will describe the reasons and consequences of mergers and acquisitions in the pharmaceutical industry by describing the challenges the pharmaceutical branch is confronted with and the respective motives of and results from M&A activities. Finally, the major findings are summarised and conclusions will be derived. 2. History of sanofi-aventis Following the company homepage of sanofi-aventis (20071), the year 1999 has been very im-portant because of two reasons. First of all, Sanofi took over the Synthelabo Holding GmbH and changed its company name to Sanofi-Synthelabo. Furthermore, Hoechst merged with Rhône-Poulenc, a French chemical and pharmaceutical organisation in order to form the new company Aventis, with its legal seat in Strassbourgh (...)

More books from GRIN Verlag

Cover of the book Mit fünf Leitsätzen besser führen by Martin Wenderoth
Cover of the book Zusammenhänge zwischen der kognitiven Entwicklungen eines Kindes und der Eigenaktivität im Schulleben by Martin Wenderoth
Cover of the book Schlafverhalten bei Schülern - Welchen Einfluss hat das Schlafverhalten auf die schulische Leistung? by Martin Wenderoth
Cover of the book Nachrichtendienste als Regierungsinstrument by Martin Wenderoth
Cover of the book Staatsorganisationsrecht. Gesetzgebungskompetenz bei Subventionen, Gesetzgebungsoutsourcing, Gewaltenteilung, Insichklage des Bundestages by Martin Wenderoth
Cover of the book XML Dokumenttyp-Definition kurz und bündig by Martin Wenderoth
Cover of the book Leben von Sozialhilfe und Schwarzarbeit by Martin Wenderoth
Cover of the book Die Reform der gymnasialen Oberstufe von 1972 - Die Beschlüsse und die Konsequenzen für den Schulalltag by Martin Wenderoth
Cover of the book Unterrichtsstunde: Der Aufbau des Limes (7. Klasse Hauptschule) by Martin Wenderoth
Cover of the book Der Anarchismus im China der frühen Republikzeit am Beispiel Liu Shifus by Martin Wenderoth
Cover of the book Islamischer Religionsunterricht an öffentlichen Schulen by Martin Wenderoth
Cover of the book Der Osterstreit von 386 by Martin Wenderoth
Cover of the book Patentzitierungen als Indikator für Innovationen by Martin Wenderoth
Cover of the book Reflexion der Lebenssituation von Menschen mit Beeinträchtigungen im Spannungsfeld von Aussonderung und Integration anhand von Beispielen aus den Hospitationen by Martin Wenderoth
Cover of the book Development of a Draft Balanced Scorecard for Zara by Martin Wenderoth
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy